IDG and Nature Reviews Drug Discovery Target Watch
Researchers supported by the IDG program will work with Nature Reviews Drug Discovery (NRDD) to develop new content on a regular basis highlighting understudied protein targets. Read the articles below to learn more about the IDG program and new proteins of interest.
- RIOK2:Straddling the kinase/ATPase line
June 26, 2019
- CDK16: the pick of the understudied PCTAIRE kinases
May 21, 2019
- Novel drug targets in 2018
March 26, 2019
This page last reviewed on July 10, 2019